These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12187167)

  • 1. Use of SEER-Medicare data for measuring cancer surgery.
    Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agreement of Medicare claims and tumor registry data for assessment of cancer-related treatment.
    Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
    Med Care; 2000 Apr; 38(4):411-21. PubMed ID: 10752973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying radiation therapy using SEER-Medicare-linked data.
    Virnig BA; Warren JL; Cooper GS; Klabunde CN; Schussler N; Freeman J
    Med Care; 2002 Aug; 40(8 Suppl):IV-49-54. PubMed ID: 12187168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of Medicare claims data for measuring cancer stage.
    Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
    Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
    Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
    Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Cancer-Directed Surgeries in Medicare Claims: A Validation Study Using SEER-Medicare Data.
    Lavery JA; Lipitz-Snyderman A; Li DG; Bach PB; Panageas KS
    JCO Clin Cancer Inform; 2019 Feb; 3():1-24. PubMed ID: 30715928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the SEER-Medicare data to identify chemotherapy use.
    Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
    Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring complications of cancer treatment using the SEER-Medicare data.
    Potosky AL; Warren JL; Riedel ER; Klabunde CN; Earle CC; Begg CB
    Med Care; 2002 Aug; 40(8 Suppl):IV-62-8. PubMed ID: 12187170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
    Gold HT; Do HT
    Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of a claims-based algorithm for classifying kidney-cancer surgeries.
    Miller DC; Saigal CS; Warren JL; Leventhal M; Deapen D; Banerjee M; Lai J; Hanley J; Litwin MS
    BMC Health Serv Res; 2009 Jun; 9():92. PubMed ID: 19500395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis date agreement between SEER and Medicare claims data: impact on treatment.
    Lin CC; Virgo KS
    Med Care; 2014 Jan; 52(1):32-7. PubMed ID: 24322987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing comorbidity using claims data: an overview.
    Klabunde CN; Warren JL; Legler JM
    Med Care; 2002 Aug; 40(8 Suppl):IV-26-35. PubMed ID: 12187165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring breast, colorectal, and prostate cancer screening with medicare claims data.
    Freeman JL; Klabunde CN; Schussler N; Warren JL; Virnig BA; Cooper GS
    Med Care; 2002 Aug; 40(8 Suppl):IV-36-42. PubMed ID: 12187166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sources.
    Schrag D; Bach PB; Dahlman C; Warren JL
    Med Care; 2002 Aug; 40(8 Suppl):IV-96-103. PubMed ID: 12187174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
    Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
    Warren JL; Klabunde CN; Schrag D; Bach PB; Riley GF
    Med Care; 2002 Aug; 40(8 Suppl):IV-3-18. PubMed ID: 12187163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sensitivity of Medicare claims data for case ascertainment of six common cancers.
    Cooper GS; Yuan Z; Stange KC; Dennis LK; Amini SB; Rimm AA
    Med Care; 1999 May; 37(5):436-44. PubMed ID: 10335746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
    McCarthy EP; Ngo LH; Chirikos TN; Roetzheim RG; Li D; Drews RE; Iezzoni LI
    Health Serv Res; 2007 Apr; 42(2):611-28. PubMed ID: 17362209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Information gained from linking SEER Cancer Registry Data to state-level hospital discharge abstracts. Surveillance, Epidemiology, and End Results.
    Brooks JM; Chrischilles E; Scott S; Ritho J; Chen-Hardee S
    Med Care; 2000 Nov; 38(11):1131-40. PubMed ID: 11078053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.